The Enterprise Value as of November 2025 (TTM) for Gene Biotherapeutics, Inc. (CRXM) is 880.93K

According to Gene Biotherapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 880.93K. This represents a change of -54.39% compared to the average of 1.93M of the last 4 quarters.

Gene Biotherapeutics, Inc. (CRXM) Historical Enterprise Value (quarterly & annually)

How has CRXM Enterprise Value performed in the past?

The mean historical Enterprise Value of Gene Biotherapeutics, Inc. over the last ten years is 6.57M. The current 880.93K Enterprise Value has changed 1.24% with respect to the historical average. Over the past ten years (40 quarters), CRXM's Enterprise Value was at its highest in in the March 2011 quarter at 27.05M. The Enterprise Value was at its lowest in in the June 2020 quarter at 466.62K.

Gene Biotherapeutics, Inc. (CRXM) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Gene Biotherapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Gene Biotherapeutics, Inc. (CRXM) Average Enterprise Value

How has CRXM Enterprise Value performed in the past?

The current Enterprise Value of Gene Biotherapeutics, Inc. (CRXM) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Gene Biotherapeutics, Inc. (CRXM) Enterprise Value vs. Peers

How is CRXM’s Enterprise Value compared to its peers?

Gene Biotherapeutics, Inc.’s Enterprise Value is less than Gelesis Holdings, Inc. (66.48M), greater than NeonMind Biosciences Inc. (0), greater than E-Qure Corp. (91.74K), greater than GeneThera, Inc. (814.80K), less than American CryoStem Corporation (1.15M), greater than Capha Pharmaceuticals Inc. (595.13K), less than Acacia Diversified Holdings, Inc. (1.24M), less than Generex Biotechnology Corporation (11.22M), greater than Navidea Biopharmaceuticals, Inc. (449.76K), greater than WPD Pharmaceuticals Inc. (706.30K),

Build a custom stock screener for Gene Biotherapeutics, Inc. (CRXM) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Gene Biotherapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Gene Biotherapeutics, Inc. (CRXM) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Gene Biotherapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.